Effect of chromium supplementation on the diabetes induced-oxidative stress in liver and brain of adult rats

• Published in: Biometals Vol. 22; no. 6; pp. 1075 - 1087
• Main Authors: Refaie, Fawzia M, Esmat, Amr Y, Mohamed, Aly F, Aboul Nour, Wael H
• Format: Journal Article
• Language: English
• Published: Dordrecht Dordrecht : Springer Netherlands 01.12.2009; Springer Netherlands; Springer Nature B.V
• Subjects: Alloxan - toxicity; Animals; Biochemistry; Biomedical and Life Sciences; Brain; Brain - metabolism; Catalase - metabolism; Cell Biology; Chromium; Chromium - metabolism; Chromium - pharmacology; Deoxyribonucleic acid; Diabetes; Diabetes Mellitus - metabolism; Diabetes Mellitus, Experimental - chemically induced; Diabetes Mellitus, Experimental - metabolism; Diabetes Mellitus, Experimental - physiopathology; Dietary supplements; Disease Models, Animal; DNA; DNA - analysis; Enzymes; Fatty acids; Glutathione Peroxidase - metabolism; Glycemic Index; Humans; Life Sciences; Lipid Peroxidation - drug effects; Liver; Liver - drug effects; Liver - metabolism; Male; Malondialdehyde - analysis; Medicine/Public Health; Microbiology; Oxidative stress; Oxidative Stress - drug effects; Oxidoreductases - metabolism; Pharmacology/Toxicology; Picolinic Acids - metabolism; Picolinic Acids - pharmacology; Plant Physiology; Protein synthesis; Proteins; Rats; Rats, Wistar; RNA - analysis; Rodents; Superoxide Dismutase - metabolism; Chromium picolinate; Brain; Palmitoyl CoA oxidase; Alloxan-diabetes; Liver; Antioxidant enzymes; Glucose; Nucleic acids; Malondialdehyde; Protein; Free fatty acids
• ISSN: 0966-0844; 1572-8773
• DOI: 10.1007/s10534-009-9258-8

This study was designed to investigate the susceptibility of liver and brain tissues, as insulin-independent tissues, of normal adult male rats to the oxidative challenge of subchronic supplementation with chromium picolinate (CrPic) at low (human equivalent) and high doses (2.90 and 13.20 μg Cr kg⁻¹ day⁻¹, respectively). Also, the modulative effect of CrPic administration on the enhanced oxidative stress in the liver and brain tissues of alloxan-diabetic rats was studied. Fasting serum glucose level was not modified in normal rats but significantly reduced in diabetic rats that had received CrPic supplement. A mild oxidative stress was observed in the liver and brain of CrPic-supplemented normal rats confirmed by the dose-dependent reductions in the levels of hepatic and cerebral free fatty acids, superoxide dismutase and glutathione peroxidase activities, and in contrast increased tissue malondialdehyde concentration. On the other hand, hepatic and cerebral catalase activity was reduced in the high dose group only. CrPic supplementation did not act as a peroxisome proliferator confirmed by the significant reductions in liver and brain peroxisomal palmitoyl CoA oxidase activity. The non significant alterations in liver protein/DNA and RNA/DNA ratios indicate that CrPic did not affect protein synthesis per cell, and that mild elevations in hepatic total protein and RNA concentrations might be due to block or decrease in the export rate of synthesized proteins from the liver to the plasma. In diabetic rats, elevated levels of hepatic and cerebral free fatty acids and malondialdehyde, and in contrast the overwhelmed antioxidant enzymes, were significantly modulated in the low dose group and near-normalized in the high dose group. The significant increases observed in liver total protein and RNA concentrations, as well as protein/DNA and RNA/DNA ratios in diabetic rats supplemented with the high dose of Cr, compared to untreated diabetics, may be related to the improvement in the glycemic status of the diabetic animals rather than the direct effect of CrPic on protein anabolism.